SG Americas Securities’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$49K Sell
23,473
-45,574
-66% -$95.1K ﹤0.01% 2428
2025
Q1
$152K Sell
69,047
-2,576
-4% -$5.67K ﹤0.01% 2429
2024
Q4
$110K Buy
71,623
+706
+1% +$1.08K ﹤0.01% 2385
2024
Q3
$141K Sell
70,917
-127,269
-64% -$253K ﹤0.01% 2482
2024
Q2
$694K Buy
+198,186
New +$694K ﹤0.01% 1372
2024
Q1
Sell
-26,464
Closed -$45K 2761
2023
Q4
$45K Sell
26,464
-4,096
-13% -$6.97K ﹤0.01% 2653
2023
Q3
$31K Buy
+30,560
New +$31K ﹤0.01% 2695
2023
Q2
Sell
-100,968
Closed -$152K 2321
2023
Q1
$152K Buy
+100,968
New +$152K ﹤0.01% 2404
2022
Q4
Sell
-14,127
Closed -$60K 2817
2022
Q3
$60K Sell
14,127
-79,139
-85% -$336K ﹤0.01% 2651
2022
Q2
$260K Buy
+93,266
New +$260K ﹤0.01% 2265
2021
Q4
Sell
-41,535
Closed -$444K 3130
2021
Q3
$444K Buy
+41,535
New +$444K ﹤0.01% 2406
2021
Q2
Sell
-18,001
Closed -$292K 2654
2021
Q1
$292K Sell
18,001
-41,897
-70% -$680K ﹤0.01% 2185
2020
Q4
$1.27M Buy
59,898
+6,195
+12% +$131K 0.01% 1233
2020
Q3
$796K Buy
53,703
+46,650
+661% +$691K 0.01% 1103
2020
Q2
$104K Sell
7,053
-48,183
-87% -$710K ﹤0.01% 2905
2020
Q1
$648K Buy
55,236
+41,459
+301% +$486K 0.01% 1303
2019
Q4
$324K Buy
13,777
+4,054
+42% +$95.3K ﹤0.01% 1839
2019
Q3
$180K Buy
+9,723
New +$180K ﹤0.01% 2070
2019
Q2
Sell
-6,181
Closed -$151K 2685
2019
Q1
$151K Buy
+6,181
New +$151K ﹤0.01% 2418
2018
Q3
Sell
-5,458
Closed -$212K 2713
2018
Q2
$212K Sell
5,458
-1,164
-18% -$45.2K ﹤0.01% 2244
2018
Q1
$183K Buy
+6,622
New +$183K ﹤0.01% 2106
2016
Q2
Sell
-7,371
Closed -$140K 2295
2016
Q1
$140K Buy
+7,371
New +$140K ﹤0.01% 2120
2014
Q3
Sell
-20,448
Closed -$252K 2251
2014
Q2
$252K Buy
+20,448
New +$252K ﹤0.01% 1696